NEW YORK (
S&P 500 and Nasdaq Set Intraday Record Highs on Recovery Optimism
Stocks rise as jobless claims fall and durable goods orders climb at the fastest pace since the beginning of the year.
) is trading at unusually high volume Monday with 35.6 million shares changing hands. It is currently at four times its average daily volume and trading down $3.02 (-20.3%) at $11.84 as of 3:30 p.m. ET.
Dendreon has a market cap of $2.08 billion and is part of the
industry. Shares are up 95.5% year to date as of the close of trading on Friday.
Dendreon Corporation, a biotechnology company, engages in the discovery, development, and commercialization of therapeutics to enhance cancer treatment options for patients. The company offers active cellular immunotherapy and small molecule product candidates to treat various cancers.
TheStreet Ratings rates Dendreon as a
. The company's weaknesses can be seen in multiple areas, such as its deteriorating net income, generally weak debt management, disappointing return on equity, poor profit margins and weak operating cash flow. You can view the full
See all heavy volume stocks in our
or get investment ideas from our
Interested in other stocks that are falling on unusually high volume? Get free SMS text alerts sent to you when the action happens by texting
to 95370 or select from